Share on LinkedInShare on LinkedIn

ARTICLE · 07 AUGUST 2013

Sunshine Act Deadline Approaching

Drinker Biddle & Reath LLP
Explore more from Drinker Biddle & Reath LLP

A discussion on why private equity firms with medical device and pharma portfolio companies need to be aware of the new Sunshine Act regulations.

United StatesCorporate/Commercial Law
Drinker Biddle'S Private Equity Practice Group
Drinker Biddle'S Private Equity Practice Group

Are you familiar with the new Sunshine Act regulations? One of our partners, Jesse Witten, explains here why private equity firms with medical device and pharma portfolio companies need to be aware of the new Sunshine Act regulations. Companies must begin to collect data on August 1, 2013, and the first annual report will be due on March 31, 2014 and will be available on the CMS public website.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Related Articles

Legal Intelligence Newsletters

Read more about

Related Comparative Guides

See more popular content from

Article

CLIENT ALERT: 2026 Mid-Year Update On SEC And CFTC Enforcement

The SEC and CFTC have fundamentally shifted their enforcement approach in 2026, moving away from high-volume technical violations toward targeted actions addressing serious fraud and market manipulation. This mid-year update examines new leadership priorities, enhanced inter-agency coordination, revised cooperation policies, the elimination of "no-deny" settlement provisions, and a landmark Supreme Court ruling on disgorgement that collectively reshape the regulatory landscape for market participants.
United StatesCorporate/Commercial Law
Sher Tremonte
Sher Tremonte
Article

No More SEC Responses To Rule 14a-8 No-Action Requests: What Public Companies Should Know For The Upcoming Proxy Season

The SEC's Division of Corporation Finance has announced it will no longer respond to Rule 14a-8 no-action requests, marking a significant shift in the shareholder proposal process. Companies must still comply with notification requirements under Rule 14a-8(j), but without staff guidance on exclusion decisions, they will need to rely on existing SEC guidance, precedent, and judicial decisions.
United StatesCorporate/Commercial Law
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC
Article

SEC Announces Dedicated Financial Reporting and Accounting Unit: Implications for Audit Committees, Boards and Public Companies

Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates is a prominent international law firm providing comprehensive legal services across multiple practice areas and jurisdictions. The firm serves clients ranging from Fortune 500 companies to emerging businesses, offering strategic counsel on complex legal matters.
United StatesCorporate/Commercial Law
Skadden Arps Slate Meagher & Flom
Skadden Arps Slate Meagher & Flom
Article

The Big Long List Of U.S. AI Laws

State legislatures across the U.S. have enacted a complex web of AI regulations affecting private sector businesses, spanning employment decisions, healthcare applications, consumer interactions, and digital rights. These laws impose compliance obligations including bias audits, disclosure requirements, and restrictions on automated decision-making, with enforcement mechanisms ranging from regulatory oversight to private rights of action. Understanding which state laws apply to your AI systems is critical,
United StatesCorporate/Commercial Law
Taft, Stettinius & Hollister LLP
Taft, Stettinius & Hollister LLP